Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Access these National Academy of Medicine and RWHAP consumer engagement tools.News Article updated on 06/23/2023
-
Recursos de Planning CHATT en Español
El Manual fue diseñado para ayudar a los miembros del consejo de planificación del Programa Ryan White de VIH/SIDA Parte A, a entender las labores y el funcionamiento de los consejos de planificación.Resource updated 01/16/2024
-
Tech/Mobile Apps Supporting HIV Care
Technology-focused tools to support HIV care engagement.Blog updated 04/10/2023
-
NIH Center Efforts Towards the EHE Initiative: Innovative Partnerships to Implement New Tools
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
-
Updates from Recent HIV Research Conferences: CROI 2020 and AIDS 2020
Review of research insights from two major HIV conferences held in 2020.Resource (Conference Presentation) updated 09/14/2023
-
New and Investigational ART Drugs and Strategies
Review of antiretroviral regimens in the clinical trials phase.Resource (Conference Presentation) updated 09/14/2023
-
Treating HIV in 2020: Interactive Cases From the Clinic(ians) and Panel Discussion
Case examples of starting antiretroviral therapy in patients under varied scenarios.Resource (Conference Presentation) updated 09/14/2023
-
Rapid ART Dissemination Assistance Provider
Project to facilitate the implementation of Rapid ART initiation in RWHAP provider settings by compiling and disseminating implementation resources nationwide. Project period: 2020-2023.RWHAP Technical Assistance Provider updated on 03/04/2024
-
Strategies and Lessons Learned for Consumer and Stakeholder Engagement in Integrated HIV Prevention and Care Planning and Implementation
Strategies for ongoing consumer and stakeholder engagement in the integrated prevention and care planning, implementation, and monitoring processes.Resource updated 05/28/2021
-
Putting Plans into Action: Roles and Responsibilities for Implementing Integrated HIV Prevention and Care Plans
Strategies to identify roles and responsibilities for implementing your five-year Integrated HIV Prevention and Care Plan.Resource updated 06/14/2023
-
AIDS at 40: Envisioning a Future We Never Imagined
June 5, 1981. Many people who work in the HIV field know its significance: the day when the first AIDS cases were officially reported.Blog updated 06/10/2021
-
Eligibility for Simplification of HIV Salvage Regimens Based on Genotypic
Resource (Conference Presentation) updated 09/14/2023
-
Developing and Utilizing a Young Adult Advisory Board (YAB) to Improve Intervention Effectiveness
Resource (Conference Presentation) updated 09/14/2023
-
Consumer Strategies for Building a Successful Consumer Advisory Board
Learn from the experience of Ugandan colleagues how case management techniques could be adopted and adapted at a facility level to improve engagement and retention of hard-to-reach patients in hopes of achieving the ultimate goal of persistent viral suppression.
Resource (Conference Presentation) updated 09/14/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024